Zealand Pharma A/S Ord
(ZLDPF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 4,925 | 2,197 | 3,143 | 43,146 | 1,521 |
| Cost of Goods | 1,369 | 669 | 2,030 | 754 | N/A |
| Gross Profit | 3,556 | 1,528 | 1,113 | 42,392 | 1,521 |
| Operating Expenses | 42,551 | 39,447 | 37,994 | 36,535 | 30,063 |
| Operating Income | -38,626 | -37,250 | -36,851 | 6,611 | -28,543 |
| Interest Expense | 8,303 | 940 | 1,841 | 862 | 20,081 |
| Other Income | 4,495 | 4,702 | 184 | 4,884 | 1,718 |
| Pre-tax Income | -42,434 | -33,488 | -38,509 | 10,633 | -46,905 |
| Income Tax | -190 | -197 | -82 | -192 | -226 |
| Net Income Continuous | -42,244 | -33,291 | -38,427 | 10,825 | -46,679 |
| Net Income | $-42,244 | $-33,291 | $-38,427 | $10,825 | $-46,679 |
| EPS Basic Total Ops | -0.67 | -0.54 | -0.65 | 0.19 | -0.80 |
| EPS Basic Continuous Ops | -0.67 | -0.54 | -0.65 | 0.19 | -0.80 |
| EPS Diluted Total Ops | -0.67 | -0.54 | -0.64 | 0.18 | -0.80 |
| EPS Diluted Continuous Ops | -0.67 | -0.54 | -0.64 | 0.18 | -0.80 |
| EPS Diluted Before Non-Recurring Items | -0.67 | -0.54 | -0.66 | N/A | N/A |
| EBITDA(a) | $-37,659 | $-36,287 | $-36,851 | $6,611 | $-28,543 |